title: Comment on "Chromosomal instability and tumors promoted by DNA hypomethylation" and "Induction of tumors in nice by genomic hypomethylation".
authors: Department of Leukemia, M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.
authors: Allen S
authors: AS
authors: Yang
authors: Marcos R H
authors: MR
authors: Estecio
authors: Guillermo
authors: G
authors: Garcia-Manero
authors: Hagop M
authors: HM
authors: Kantarjian
authors: Jean-Pierre J
authors: JP
authors: Issa
mesh_terms: D000818:Animals; D001374:Azacitidine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D043171:Chromosomal Instability; D000076123:DNA (Cytosine-5-)-Methyltransferase 1; D004248:DNA (Cytosine-5-)-Methyltransferases / Q000037:antagonists & inhibitors / Q000378:metabolism; D019175:DNA Methylation; D000077209:Decitabine; D017491:Genes, APC; D006801:Humans; D015994:Incidence; D007414:Intestinal Neoplasms / Q000453:epidemiology / Q000517:prevention & control; D051379:Mice; D009369:Neoplasms / Q000209:etiology / Q000235:genetics* / Q000517:prevention & control; D017354:Point Mutation; D013997:Time Factors
chemical_list: D000077209:Decitabine; D000076123:DNA (Cytosine-5-)-Methyltransferase 1; D004248:DNA (Cytosine-5-)-Methyltransferases; D001374:Azacitidine